Interleukin-6 induced suppression of bovine parathyroid hormone secretion

Area of Science:

• Endocrinology
• Critical Care Medicine
• Immunology

Background:

• Critical illness is often associated with calcium disturbances.
• Pro-inflammatory cytokines, such as TNF-alpha and IL-6, are elevated in critically ill patients.
• The impact of these cytokines on parathyroid hormone (PTH) secretion, a key regulator of calcium homeostasis, is not fully understood.

Purpose of the Study:

• To investigate the effects of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) on parathyroid hormone (PTH) secretion in vitro.
• To determine if these cytokines influence intracellular calcium concentrations in parathyroid cells.

Main Methods:

• Parathyroid cells were cultured with varying extracellular calcium (Ca2+) concentrations (0.5, 1.25, and 3.0 mM).
• Cells were treated with TNF-alpha and IL-6 (10 ng/mL) for acute and 24-hour periods.
• PTH secretion was measured, and intracellular calcium levels were assessed.

Main Results:

• Neither IL-6 nor TNF-alpha acutely affected PTH secretion across different Ca2+ concentrations.
• However, 24-hour incubation with IL-6 significantly decreased PTH secretion by 51% at 0.5 mM Ca2+ and 29% at 1.25 mM Ca2+.
• IL-6 and TNF-alpha did not alter intracellular calcium concentrations in the parathyroid cells.

Conclusions:

• Interleukin-6 (IL-6) can suppress parathyroid hormone (PTH) secretion in vitro at clinically relevant concentrations.
• This IL-6-induced suppression of PTH may exacerbate hypocalcemia in critically ill patients.
• The findings suggest that IL-6 may interfere with the normal PTH response to low serum calcium levels.